eShowcase: Velos eResearch Version 7
New clinical trial software version provides direct data capture at investigator sites
New clinical trial software version provides direct data capture at investigator sites
Velos, Inc. (Fremont, CA) has released Velos eResearch Version 7 for increased features and functions for large investigative sites. Velos eResearch is a clinical trial management software system.
Velos eResearch Version 7 provides direct capture of clinical trial data, eliminating duplicate data entry. This in turn allows the systems used at the site to generate better or higher quality research data, and offer improved efficiency and productivity for investigators and sponsors.
Velos eResearch 7 uses Web 2.0 technology and system design. It features HL7 compliance, support for study administration, clinical data management, adverse event reporting, compliance with industry standards (including CFR Part 11), patient- and study-level architecture, and advanced security to large multi-institutional clinical studies.
Velos, Inc., (510) 739-4010, www.velos.com
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
